John Aballi
President and CEO at Exagen · 3 reported transactions in 1 company · latest trade Oct 16, 2026
Their trades
Sold | Oct 16, 2026 | Oct 16, 2026 close $7.72 → Oct 29, 2026 close $8.70. S&P 500 +1.2% over the same days. | ||
Sold | Feb 24, 2026 | Feb 24, 2026 close $3.69 → Oct 29, 2026 close $8.70. S&P 500 +12.4% over the same days. | ||
Sold | Oct 16, 2025 | Oct 16, 2025 close $11.77 → Oct 29, 2026 close $8.70. S&P 500 +16.9% over the same days. |
SoldExagen
$269.8K
Oct 16, 2026 close $7.72 → Oct 29, 2026 close $8.70. S&P 500 +1.2% over the same days.
SoldExagen
$41.3K
Feb 24, 2026 close $3.69 → Oct 29, 2026 close $8.70. S&P 500 +12.4% over the same days.
SoldExagen
$375.6K
Oct 16, 2025 close $11.77 → Oct 29, 2026 close $8.70. S&P 500 +16.9% over the same days.